Department of Psychology, Universidad Loyola Andalucía, Dos Hermanas, Spain.
Department of Health Psychology, Universidad Miguel Hernández de Elche, Elche, Spain.
J Womens Health (Larchmt). 2023 May;32(5):583-591. doi: 10.1089/jwh.2022.0400. Epub 2023 Feb 14.
Evidence of post-traumatic stress disorder (PTSD) symptoms related to the COVID-19 pandemic during the perinatal period and the associated risk factors are still limited. Thus, we aimed to investigate the PTSD symptoms associated with the COVID-19 pandemic in a large sample of both pregnant and postpartum women. A cross-sectional study was conducted on 3319 pregnant and up to 6-month postpartum women from Spain. An online survey was completed between June 2020 and January 2021. The assessment included measures of PTSD symptoms associated with COVID-19 (evaluated with 10 questions from the PTSD checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition), pandemic-related concerns and health background (assessed by the Coronavirus Perinatal Experiences-Impact Survey), and demographic characteristics. We found that >40% of women suffered from symptoms of PTSD associated with the COVID-19 pandemic. Difficulty concentrating and irritability were the most common symptoms, showing marked alterations in arousal and reactivity associated with the traumatic event. Being younger, suffering from pandemic concerns and distress, changes due to the pandemic and previous mental health problems were risk factors associated with PTSD symptoms in perinatal women. In addition, whereas being an immigrant (non-Spanish) was a risk factor for pregnant women, having other children and financial problems were risk factors for postpartum women. COVID-19 infection did not appear to be a risk factor for symptoms of PTSD in perinatal women. The increased risk of PTSD in pregnant and postpartum women highlights the importance of early detection and treatment of PTSD for pregnant and postnatal women, both during and beyond the pandemic. ClinicalTrials.gov Identifier (NCT04595123).
围产期与 COVID-19 大流行相关的创伤后应激障碍(PTSD)症状的证据以及相关的危险因素仍然有限。因此,我们旨在调查西班牙大量孕妇和产后妇女与 COVID-19 大流行相关的 PTSD 症状。 一项横断面研究对来自西班牙的 3319 名孕妇和产后 6 个月内的妇女进行了研究。2020 年 6 月至 2021 年 1 月期间完成了在线调查。评估包括与 COVID-19 相关的 PTSD 症状评估(使用《精神障碍诊断与统计手册》第五版 PTSD 清单中的 10 个问题进行评估)、与大流行相关的担忧和健康背景(使用冠状病毒围产期影响调查评估)以及人口统计学特征。 我们发现,超过 40%的女性患有与 COVID-19 大流行相关的 PTSD 症状。注意力不集中和易怒是最常见的症状,表现出与创伤性事件相关的警觉和反应性明显改变。年龄较小、受大流行担忧和困扰、大流行导致的变化以及先前的心理健康问题是围产期妇女 PTSD 症状的危险因素。此外,虽然移民(非西班牙裔)是孕妇的危险因素,但有其他孩子和经济问题是产后妇女的危险因素。COVID-19 感染似乎不是围产期妇女 PTSD 症状的危险因素。 妊娠和产后妇女 PTSD 风险增加强调了在大流行期间和之后,早期发现和治疗妊娠和产后妇女 PTSD 的重要性。 临床试验.gov 标识符(NCT04595123)。